Login
From:
Pulmonary Fibrosis News
(Uncensored)
subscribe
IPF treatment, NXP002, Continues to Show Promise in Preclinical Studies
https://pulmonaryfibrosisnews.com/news/nuformixs-nxp002-ipf-shows-promise-preclinical-studies/
links
backlinks
Tagged with:
idiopathic pulmonary fibrosis
tranilast
nxp002
nuformix
preclinical studies
esbriet
ofev
The inhaled NXP002 achieves significant levels in the lungs and lowers the production of scarring-promoting molecules, a study shows.
Roast topics
Find topics
Find it!
